KATHERINE VAN HOVELN: Open Payments
NPI 1538720008 · WATSEKA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 46 payments from 12 companies in 2025. Trend: 2023 $683 · 2024 $684 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $167 |
| GlaxoSmithKline, LLC. | 10 | $150 |
| Novo Nordisk Inc | 10 | $148 |
| Lilly USA, LLC | 5 | $75 |
| ABBVIE INC. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, Ozempic, MOUNJARO, JARDIANCE, REXULTI, Wegovy, VRAYLAR.
Industry payments across IL — which companies pay providers there.
